Karyopharm Therapeutics Inc (KPTI)
1.035
-0.02
(-2.36%)
USD |
NASDAQ |
Apr 26, 11:31
Karyopharm Therapeutics Total Long Term Debt (Quarterly): 170.92M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 170.92M |
September 30, 2023 | 170.70M |
June 30, 2023 | 170.50M |
March 31, 2023 | 170.31M |
December 31, 2022 | 170.10M |
September 30, 2022 | 169.89M |
June 30, 2022 | 169.69M |
March 31, 2022 | 169.49M |
December 31, 2021 | 169.29M |
September 30, 2021 | 169.09M |
June 30, 2021 | 168.90M |
March 31, 2021 | 168.70M |
December 31, 2020 | 117.93M |
September 30, 2020 | 115.80M |
June 30, 2020 | 113.78M |
March 31, 2020 | 111.77M |
December 31, 2019 | 109.86M |
September 30, 2019 | 107.96M |
June 30, 2019 | 106.16M |
March 31, 2019 | 104.37M |
December 31, 2018 | 102.66M |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
Date | Value |
---|---|
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
106.16M
Minimum
Jun 2019
170.92M
Maximum
Dec 2023
148.47M
Average
169.09M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
Geron Corp | 81.94M |
Arbutus Biopharma Corp | 0.00 |
Verastem Inc | -- |
Actinium Pharmaceuticals Inc | 0.00 |
Chimerix Inc | 0.125M |